← FDA Drug Approvals (Drugs@FDA)

DESMOPRESSIN ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2019-06-06

Drug application

FDA Application #
ANDA208357
Application type
Abbreviated New Drug Application (Generic)
Brand name
DESMOPRESSIN ACETATE
Generic name
Desmopressin Acetate
Active ingredients
DESMOPRESSIN ACETATE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
NOVAST LABS
First approval
2019-06-06

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown